BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa
Menu

Report Library

All Reports
Datamonitor Healthcare Oncology: Acute Lymphoblastic Leukemia (ALL) Disease Coverage

Retail Price: $22,000.00

*BioMedTracker Subscriber Price: $15,000.00 - click here to log in

July 06, 2018

Acute lymphoblastic leukemia (ALL) is a hematological disease that is characterized by the proliferation of immature lymphoid cells in the bone marrow and peripheral blood. ALL is typically a disease of childhood, with over 70% of cases affecting children. Current treatment regimens have led to a cure rate of approximately 80% for children with ALL. However, the long-term prognosis for adult patients with ALL remains poor, with cure rates of only 30–40%.

This Datamonitor Healthcare Disease Coverage report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.

Disease Group Covered: Oncology
Back to the top Back to the top